NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Cellupep? Mail in a sample (US only) and let us test it.

Test my supply
+8 more ↓
63%
Finnrick rating
#364 of 457 ranked vendors
27 of 41 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Cellupep's purity-focused record is strongest in Retatrutide and GHK-Cu, with repeated high-purity Retatrutide results and GHK-Cu recovering after a severe overfill outlier. BPC-157 and TB-500 are weaker: both show later purity misses, TB-500 also has overfill, and uneven batch IDs make the evidence more dispersed despite solid volume.

methodology →
vendor intelligence report
Vendor Intelligence Report: Cellupep

Corporate and domain records point to a recent, privacy-protected operation behind Cellupep’s manufacturer-style claims. The full report follows the COA gallery, UK/HK contact layer, European storefront, and mixed fulfillment trail without relying on vendor screenshots.

26 pages6 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
85%
5
2
Retatrutide
$1.00
79%
16
3
Tirzepatide
$0.48
79%
7
4
Tesamorelin
$2.00
48%
4
5
BPC-157
$0.75
41%
6
6
TB-500
$1.26
40%
4
7
Glutathione
$0.01
-
0
8
HGH
$1.33
-
0
9
Ipamorelin
$1.10
-
0
10
KPV
$0.50
-
0
11
MOTS-c
$0.68
-
0
12
NAD+
$0.01
-
0
13
PT-141
$0.75
-
0
15
SS-31
$0.84
-
0
16
Wolverine
$0.85
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%23 Oct 2025: 25%17 Nov 2025: 44%17 Nov 2025: 52%25 Nov 2025: 46%13 Dec 2025: 46%17 Dec 2025: 46%7 Jan 2026: 47%7 Jan 2026: 47%26 Jan 2026: 47%26 Jan 2026: 46%18 Feb 2026: 53%18 Feb 2026: 57%18 Feb 2026: 59%18 Feb 2026: 59%18 Feb 2026: 60%18 Feb 2026: 60%20 Feb 2026: 60%20 Feb 2026: 61%20 Feb 2026: 61%22 Feb 2026: 60%22 Feb 2026: 60%17 Mar 2026: 62%17 Mar 2026: 62%18 Mar 2026: 62%19 Mar 2026: 62%19 Mar 2026: 61%22 Mar 2026: 62%25 Mar 2026: 62%28 Apr 2026: 62%28 Apr 2026: 61%11 May 2026: 62%11 May 2026: 62%13 Jul 2026: 62%13 Jul 2026: 62%20 Jul 2026: 62%2 Aug 2026: 64%3 Aug 2026: 64%3 Aug 2026: 65%9 Aug 2026: 64%9 Aug 2026: 63%7 Oct 2026: current 63%25%59%63%Oct 25Oct 26
Free peptide testing

Ordered peptides from Cellupep? Mail in a sample (US only) and let us test it.

Test my supply
Cellupep test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
9 Aug 2026
Fail
Tirzepatide
lab nameView COA
9 Aug 2026
Fail
Retatrutide
lab nameView COA
3 Aug 2026
Pass
Tirzepatide
lab nameView COA
3 Aug 2026
Pass
Retatrutide
lab nameView COA
2 Aug 2026
Pass
Tesamorelin
lab nameView COA
20 Jul 2026
Pass
Tirzepatide
lab nameView COA
20 Jul 2026
Incomplete
Tirzepatide
lab nameView COA
13 Jul 2026
Fail
BPC-157
lab nameView COA
13 Jul 2026
Pass
Retatrutide
lab nameView COA
11 May 2026
Pass
Retatrutide
lab nameView COA
1-10 of 42

About Cellupep test results from Finnrick

Cellupep is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 42 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Cellupep peptides in this dataset are BPC-157 (6 tests), GHK-Cu (5 tests) and Retatrutide (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 42 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Cellupep? Mail in a sample (US only) and let us test it.

Test my supply